GCP
ABVX

GSA Capital Partners’s Abivax ABVX Stock Holding History

GSA Capital Partners’s Portfolio ABVX Stock Details ABVX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$207K Buy
+1,857
New +$220K 0.01% 1441

Other funds holding ABVX

TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.77B AUM 307.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
CP
Caligan Partners New York $1.5B AUM 518.95% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
HI
Helikon Investments London, United Kingdom $2.65B AUM 79.03% 1-Year Est. Return

GSA Capital Partners's ABVX Position: Q1 2026 in Review

GSA Capital Partners opened a new position in Abivax (ABVX) in Q1 2026: 1,857 shares worth $207K. The stake represents 0.01% of the portfolio and ranks #1441 among its holdings.

254 funds tracked by Wall St. Rank hold ABVX as of Q1 2026.

  • GSA Capital Partners held 1,857 shares of Abivax worth $207K as of Q1 2026.
  • Abivax was a new GSA Capital Partners position in Q1 2026.
  • Abivax made up 0.01% of GSA Capital Partners's portfolio in Q1 2026, its #1441 holding.
  • 254 funds tracked by Wall St. Rank held Abivax as of Q1 2026.

Based on GSA Capital Partners's 13F filing for Q1 2026, filed 8 May 2026.